Erratum: Peroxisome proliferator-activated receptor γ gene polymorphisms and restenosis in diabetic patients after stenting in coronary arteries (Diabetologia (2004) 47 (1126-1127) DOI: org/10.1007/s00125-004-1406-7);Peroxisome proliferator-activated receptor g gene polymorphisms and restenosis in diabetic patients after stenting in coronary arteries [1]

Diabetologia

Volumn 47, Issue 6, 2004, Pages 1126-1127

  Koch, W ^a   Jung, V ^a   Von Beckerath, N ^a   Schomig A ^a   Kastrati, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

AMINO ACID SUBSTITUTION; ANGIOGRAPHY; BINDING AFFINITY; CAUSE OF DEATH; CONFIDENCE INTERVAL; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; FOLLOW UP; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INSULIN SENSITIVITY; LETTER; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RESTENOSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 3142674996     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1520-6     Document Type: Erratum

References (8)

1. Elezi S, Kastrati A, Pache J et al. (1998) Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 32:1866-1873
2. Hoffmann R, Mintz GS, Dussaillant GR et al. (1996) Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94:1247-1254
3. Barbier O, Torra IP, Duguay Y et al. (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 22:717-726
4. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK (2003) PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 100:6712-6717
5. Takagi T, Akasaka T, Yamamuro A et al. (2000) Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study. J Am Coll Cardiol 36:1529-1535
6. Altshuler D, Hirschhorn JN, Klannemark M et al. (2000) The common PPARgamma Pro12A1a polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
7. Berger J, Moller DE (2002) The mechanisms of action of PPARs. Annu Rev Med 53:409-435
8. Auwerx J (1999) PPARgamma, the ultimate thrifty gene. Diabetologia 42:1033-1049